196 related articles for article (PubMed ID: 14636245)
1. Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively.
Zhong J; Gilbertson B; Cheers C
Immunol Cell Biol; 2003 Dec; 81(6):480-6. PubMed ID: 14636245
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
3. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
4. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
5. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
Tateyama M; Oyaizu N; McCloskey TW; Than S; Pahwa S
Blood; 2000 Jul; 96(1):195-202. PubMed ID: 10891451
[TBL] [Abstract][Full Text] [Related]
6. Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8
Yajima T; Hoshino K; Muranushi R; Mogi A; Onozato R; Yamaki E; Kosaka T; Tanaka S; Shirabe K; Yoshikai Y; Kuwano H
Mol Immunol; 2019 Mar; 107():97-105. PubMed ID: 30711908
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
[TBL] [Abstract][Full Text] [Related]
8. Effect of Icariin on apoptosis and expression of Fas, Fas ligand, B cell lymphoma, and Bcl-2-associated X protein in CD4+ T lymphocytes from patients with ankylosing spondylitis.
Wang H; Jiang Q; Feng X
J Tradit Chin Med; 2017 Apr; 37(2):207-13. PubMed ID: 29960293
[TBL] [Abstract][Full Text] [Related]
9. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
10. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
[TBL] [Abstract][Full Text] [Related]
11. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.
Süss G; Shortman K
J Exp Med; 1996 Apr; 183(4):1789-96. PubMed ID: 8666935
[TBL] [Abstract][Full Text] [Related]
12. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
13. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice.
Flórido M; Appelberg R
J Immunol; 2007 Dec; 179(11):7702-8. PubMed ID: 18025216
[TBL] [Abstract][Full Text] [Related]
15. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
16. Expression of FasR, Fas-L and Bcl-2 in CD4+ and CD8+ subpopulations of T lymphocytes in the cord blood of healthy full-term newborns, is gender of influence?
Wasiluk A; Ratomski K; Wnuczko K; Zak J; Szczepański M; Wysocka J; Jasińska EA
Adv Med Sci; 2009; 54(1):99-103. PubMed ID: 19482726
[TBL] [Abstract][Full Text] [Related]
17. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
[TBL] [Abstract][Full Text] [Related]
19. Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.
Kremer L; Estaquier J; Wolowczuk I; Biet F; Ameisen JC; Locht C
Infect Immun; 2000 Jul; 68(7):4264-73. PubMed ID: 10858244
[TBL] [Abstract][Full Text] [Related]
20. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
